Relationship between TNFA, TNFB and TNFRII gene polymorphisms and outcome after unrelated hematopoietic cell transplantation in a Chinese population

[1]  H. Einsele,et al.  Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial. , 2009, The Lancet. Oncology.

[2]  L. Zhao,et al.  IL10 and IL10 Receptor Gene Variation and Outcomes After Unrelated and Related Hematopoietic Cell Transplantation , 2009, Transplantation.

[3]  B. Das,et al.  Association of single nucleotide polymorphisms (SNPs) in TNF-LTA locus with breast cancer risk in Indian population , 2009, Breast Cancer Research and Treatment.

[4]  R. Gale,et al.  Risk factors for acute graft-versus-host disease after human leukocyte antigen-identical sibling transplants for adults with leukemia. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  Jienny Lee,et al.  Mycophenolate mofetil promotes down-regulation of expanded B cells and production of TNF-alpha in an experimental murine model of colitis. , 2008, Cytokine.

[6]  R. Egeler,et al.  Acute GvHD: pathogenesis and classification , 2008, Bone Marrow Transplantation.

[7]  E. Holler,et al.  Polymorphisms of cytokine and innate immunity genes and GVHD. , 2008, Best practice & research. Clinical haematology.

[8]  P. Reddy,et al.  Biological advances in acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. , 2008, Transplantation.

[9]  A. Elmaagacli,et al.  Relation of an interleukin-23 receptor gene polymorphism to graft-versus-host disease after hematopoietic-cell transplantation , 2008, Bone Marrow Transplantation.

[10]  B. Ghosh,et al.  Association of TNF polymorphisms with sarcoidosis, its prognosis and tumour necrosis factor (TNF)‐α levels in Asian Indians , 2007, Clinical and experimental immunology.

[11]  D. Ray,et al.  Glucocorticoid receptor gene polymorphisms and susceptibility to rheumatoid arthritis , 2007, Clinical endocrinology.

[12]  C. Mullighan,et al.  New directions in the genomics of allogeneic hematopoietic stem cell transplantation. , 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[13]  F. Locatelli,et al.  Recombinant human soluble tumor necrosis factor receptor fusion protein as treatment for steroid refractory graft‐versus‐host disease following allogeneic hematopoietic stem cell transplantation , 2007, American journal of hematology.

[14]  S. Chanock,et al.  Genetic variation in tumor necrosis factor and lymphotoxin-alpha (TNF–LTA) and breast cancer risk , 2007, Human Genetics.

[15]  K. Bendtzen,et al.  Differential effect of conditioning regimens on cytokine responses during allogeneic stem cell transplantation , 2006, Bone Marrow Transplantation.

[16]  J. Ferrara,et al.  Pathophysiology of graft-versus-host disease. , 2006, Seminars in hematology.

[17]  A. Sajantila,et al.  CYP2D6 Genotyping by a Multiplex Primer Extension , 2005 .

[18]  L. Karabon,et al.  Lack of IFN-gamma 2/2 homozygous genotype independently of recipient age and intensity of conditioning regimen influences the risk of aGVHD manifestation after HLA-matched sibling haematopoietic stem cell transplantation , 2004, Bone Marrow Transplantation.

[19]  Ming-Tseh Lin,et al.  Relation of an interleukin-10 promoter polymorphism to graft-versus-host disease and survival after hematopoietic-cell transplantation. , 2003, The New England journal of medicine.

[20]  R. Porcher,et al.  Host defense and inflammatory gene polymorphisms are associated with outcomes after HLA-identical sibling bone marrow transplantation. , 2002, Blood.

[21]  Bert Vogelstein,et al.  Allelic Variation in Human Gene Expression , 2002, Science.

[22]  H. Inoko,et al.  Polymorphisms in TNFA and TNFR2 affect outcome of unrelated bone marrow transplantation , 2002, Bone Marrow Transplantation.

[23]  D. Thiele,et al.  TNF-TNFR2 Interactions Are Critical for the Development of Intestinal Graft-Versus-Host Disease in MHC Class II-Disparate (C57BL/6J→C57BL/6J × bm12)F1 Mice1 , 2002, The Journal of Immunology.

[24]  Rachel L. Mistur,et al.  Graft-Versus-Host Disease , 2016 .

[25]  T. Horiuchi,et al.  Association of tumor necrosis factor receptor type II polymorphism 196R with Systemic lupus erythematosus in the Japanese: molecular and functional analysis. , 2001, Arthritis and rheumatism.

[26]  A. Janin,et al.  Both genetic and clinical factors predict the development of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. , 2001, Transplantation.

[27]  A. Silman,et al.  Association between rheumatoid arthritis and polymorphism of tumor necrosis factor receptor II, but not tumor necrosis factor receptor I, in Caucasians. , 2001, Arthritis and rheumatism.

[28]  D. Thiele,et al.  Enhancement of MHC class I‐stimulated alloresponses by TNF/TNF receptor (TNFR)1 interactions and of MHC class II‐stimulated alloresponses by TNF/TNFR2 interactions , 2000, European journal of immunology.

[29]  R. Allen.  Polymorphism of the human TNF-α promoter — random variation or functional diversity? , 1999 .

[30]  R. Allen.  Polymorphism of the human TNF-alpha promoter--random variation or functional diversity? , 1999, Molecular immunology.

[31]  J. Crawford,et al.  Tumor necrosis factor- alpha production to lipopolysaccharide stimulation by donor cells predicts the severity of experimental acute graft-versus-host disease. , 1998, The Journal of clinical investigation.

[32]  G. Jackson,et al.  Cytokine gene polymorphisms associating with severe acute graft-versus-host disease in HLA-identical sibling transplants. , 1998, Blood.

[33]  J. Crawford,et al.  Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines. , 1997, Blood.

[34]  E. Mozes,et al.  Cytokine manipulation by methotrexate treatment in murine experimental systemic lupus erythematosus. , 1997, The Journal of rheumatology.

[35]  W. R. Lamb,et al.  A genetic marker of high TNF-α production in heart transplant recipients , 1995 .

[36]  E D Thomas,et al.  1994 Consensus Conference on Acute GVHD Grading. , 1995, Bone marrow transplantation.

[37]  W. R. Lamb,et al.  A genetic marker of high TNF-alpha production in heart transplant recipients. , 1995, Transplantation.

[38]  F. Pociot,et al.  A Tumour Necrosis Factor Beta Gene Polymorphism in Relation to Monokine Secretion and Insulin‐Dependent Diabetes Mellitus , 1991, Scandinavian journal of immunology.

[39]  W. Lehmacher,et al.  Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation. , 1990, Blood.

[40]  W. Lehmacher,et al.  Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation. , 1990, Blood.